The binding of microorganisms to platelets is a critical step in the development of infective endocarditis. In Streptococcus gordonii, this binding is mediated in part by serine-rich repeat proteins, which interact directly with sialic acid residues located on GPIIb receptors in the platelet membrane. In this study, we found that S. gordonii DL1 strain binds to platelets through bridging between sialic acid residue of fibronectin and serine-rich repeat protein (Hsa). Pretreatment of fibronectin with sialidases specific for α(2-3)-linked sialic acids was shown to significantly inhibit binding of the DL1 strain and the binding region(BR) of Hsa protein. Similarly, pre-incubation of bacteria or BR of Hsa with α(2-3)-sialyl-N-acetyllactosamine blocked fibronectin binding in the DL1 strain, but not the M99 strain. Together, these data show that the α(2-3)-sialic acid residues of fibronectin play an important role in the binding of S. gordonii DL1 to fibronectin through interactions with the Hsa receptor. This interaction is thought to play an important role in the development of pathogenic endocarditis, and may represent an important therapeutic target for the treatment of infective endocarditis.
INTRODUCTION
The pathogenesis of infective endocarditis is a complex process, involving multiple host-pathogen interactions (1~3).
A key aspect of this process is the binding of microbes to human components, including platelets, fibrinogen, fibronectin, and other matrix proteins (4~8). These interactions appear to be important both for the initial attachment of bacteria to the endovascular surface, and for the subsequent deposition of bacteria, immune cells, and blood components (1) . However, despite the importance of these interactions in pathogenesis, a limited number of adhesins have been identified, primarily for Staphylococcus aureus.
Streptococcus gordonii comprises a large portion of the commensal bacteria present in the oral cavity (9, 10) . These bacteria are known to frequently enter the bloodstream following trauma to the oral tissues, and can adhere to abnormal or previously damaged heart valves (11) . Despite its importance as a human pathogen, relatively little is known about its virulence determinants, particularly with regard to its interactions with plasma extracellular matrix 317 proteins. Many Gram-positive bacteria are able to adhere to platelets via fibrinogen or fibronectin, which acts as a molecular bridge between the bacterium and platelet surface (5, 12~18) . Although numerous S. gordonii fibronectin binding proteins have been identified, the biochemical mechanisms underlying these interactions remain poorly understood (19, 20) .
S. gordonii serine-rich repeat (SRR) glycoproteins such as GspB or Hsa are likely to facilitate adherence to human platelets through interactions with host carbohydrates (9, 19) . S. gordonii strain DL1 has been shown to bind human fibronectin via Hsa (21) . Inhibition of this interaction leads to attenuated virulence in the setting of infective endocarditis; however, the molecular mechanism underlying this interaction is unknown. Here, we report Hsa binding to a specific carbohydrate motif of human fibronectin located between two SRR domains. Moreover, we demonstrate that Hsa exhibits significantly higher binding affinity for fibronectin as compared to GspB expressed by S. gordonii strain M99.
MATERIALS AND METHODS

Reagents
Purified human fibrinogen, fibronectin, thrombin, laminin, collagen, and plasminogen were obtained from Haematologic Ninety-six-well microtiter plates were obtained from SPL (Pocheon, Korea). [27] pGEX-gspB Vector for expression of GspB [27] 
Strains and growth conditions
The bacterial strains used in this study are listed in Table   1 . All streptococci were grown in Todd-Hewitt broth were then performed, as described above. followed by blocking with a casein-based blocking solution.
Purification of GspB-BR and Hsa-BR
GST-tagged GspB-BR-and
Protein binding assays were then performed as described above.
Inhibition of fibronectin binding by sialyl-Nacetyllactosamine
Bacteria and purified proteins were co-incubated with 100 μM α(2-3)-sialyl-N-acetyllactosamine or α(2-6)-sialyl-N-acetyllactosamine (Sigma) in wells containing immobilized fibronectin. The wells were then washed and the corresponding bacteria and protein binding assays were performed, as described above. 
Data analyses
All data were analyzed using an unpaired t-test and are expressed as means ± standard deviation (SD) values.
P-values ≤ 0.05 were considered statistically significant.
RESULTS
Glycoprotein Hsa mediates S. gordonii DL1 binding to fibronectin
First, we measured the adherence of S. gordonii strains to a variety of host plasma and matrix proteins. Streptococcus gordonii strain DL1 adhered to immobilized human fibronectin at levels significantly higher than that of other proteins ( Fig. 2A) . Similar analyses were performed to examine the binding of five S. gordonii strains, three Streptococcus sanguinis strains, and one Group B streptococcal COH31 strain (24) to immobilized fibronectin (Fig. 2B ).
All other bacteria showed significantly lower binding to fibronectin compared to the DL1 strain, indicative of a strain-specific adaptation in S. gordonii DL1 allowing for increased adherence to immobilized fibronectin.
As the DL1 strain has previously been shown to express the SRR glycoprotein Hsa, an adherence molecule critical for binding to human platelets (25~27), we examined the impact of Hsa expression on binding to fibronectin. The deletion of hsa markedly reduced DL1 binding to fibronectin (Fig. 3A) . Similar results were observed in S. gordonii strains M99 and 70~40; however, their binding affinity was significant lower than that of DL1. These results indicate that DL1 binding to immobilized fibronectin is mediated by surface-expressed Hsa.
The well-characterized cell wall-anchored glycoprotein GspB of S. gordonii M99 binds human platelets through its interaction with sialyl-T antigen (19) . To determine the effect of GspB homolog, Hsa on fibronectin binding, we assessed the binding of M99, DL1, and 70~40 to fibronectin following treatment with sialidase A. Pretreatment with sialidase A had no effect on fibronectin binding in any of the Srr mutant strains (Fig. 3B) , whereas binding of the DL1 strain was significantly reduced following sialidase A treatment. In contrast, the other two strains showed only slight reductions in fibronectin binding. These results suggest that DL1 binding to immobilized fibronectin is mediated by Pretreatment of GspB-BR had no effect on its binding to fibronectin, whereas the Hsa-BR construct exhibited a significant reduction in binding when pretreated with α(2-3) sialyl-N-acetyllactosamine (Fig. 5B) . Taken together, these data suggest that the DL1 strain binds to fibronectin in part through interactions between the surface protein Hsa and α(2-3) sialic acid. In contrast, the GspB protein of strain Moreover, although GspB binds with similar affinity to the platelet membrane receptor GPIIb, its binding was significant lower to fibronectin. The data presented here, along with those of previous studies, suggest that Hsa recognizes specific α(2-3) sialic acid residues, which are highly expressed on fibronectin but not on GPIIb receptor molecules. Further research will be necessary to understand the precise basis of Hsa binding to the sialic acid residues of fibronectin and the role of this interaction in colonization and infection.
